Identification of children in the first four years of life for early treatment for otitis media with effusion

Abstract

The identified randomised trials do not show an important benefit on language development and behaviour from screening of the general population of asymptomatic children in the first four years of life for OME. However, these trials were all conducted in developed countries. Evidence generated in the developed world, where children may enjoy better nutrition, better living conditions and less severe and different infections may not be applicable to children in developing countries. The screening aspect of some of these studies was aimed primarily at identifying suitable children in whom to evaluate the effects of treatment, rather than to evaluate the effects of screening programs. Younger children and children with milder disease may have been included in these treatment trials compared to children who are offered treatment in pragmatic settings.

Absent otoacoustic emissions predict otitis media in young Aboriginal children: A birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia

“…Prevalence The burden of OM and age-specific prevalence in non-Aboriginal children is comparable to that found in studies undertaken elsewhere [1,27,28]. In Aboriginal children, the age-specific prevalence of OM, and specifically the prevalence of TM perforations, in this urban/periurban semi-arid area of WA is lower than in many communities in the NT and WA, though prevalence of disease varies widely between communities [11,29,30].…”

Absent otoacoustic emissions predict otitis media in young Aboriginal children: A birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia

“…Prevalence The burden of OM and age-specific prevalence in non-Aboriginal children is comparable to that found in studies undertaken elsewhere [1,27,28]. In Aboriginal children, the age-specific prevalence of OM, and specifically the prevalence of TM perforations, in this urban/periurban semi-arid area of WA is lower than in many communities in the NT and WA, though prevalence of disease varies widely between communities [11,29,30].…”

Middle ear disease in Aboriginal children in Perth: analysis of hearing screening data, 1998–2004

“…Consistent with findings reported elsewhere, there was a significant reduction in OME with increasing age. However, the proportion of children in the ≥ 10‐years age group with OME (11.4%) is higher than the 3%–8% reported for non‐Aboriginal children after the age of 7 years 16 . We also found a significant difference in the occurrence of hearing loss according to age, with older children less likely than younger children to suffer mild or moderate hearing loss.…”

Hearing, Speech, Language, and Communicative Participation in Patients With Apert Syndrome: Analysis of Correlation With Fibroblast Growth Factor Receptor 2 Mutation

“…However, this study did not analyze results by genotype. This is important, because in the general population, the prevalence of OME is 20% at approximately 2 years of age, reducing to 8% by 7 to 8 years of age 65,66,67 . Results of the present study indicated that for patients with a S252W mutation, HL was recorded as long-term for 65% of patients.…”

Absent otoacoustic emissions predict otitis media in young Aboriginal children: A birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia

“…Prevalence The burden of OM and age-specific prevalence in non-Aboriginal children is comparable to that found in studies undertaken elsewhere [1,27,28]. In Aboriginal children, the age-specific prevalence of OM, and specifically the prevalence of TM perforations, in this urban/periurban semi-arid area of WA is lower than in many communities in the NT and WA, though prevalence of disease varies widely between communities [11,29,30].…”

Middle ear disease in Aboriginal children in Perth: analysis of hearing screening data, 1998–2004

“…Consistent with findings reported elsewhere, there was a significant reduction in OME with increasing age. However, the proportion of children in the ≥ 10‐years age group with OME (11.4%) is higher than the 3%–8% reported for non‐Aboriginal children after the age of 7 years 16 . We also found a significant difference in the occurrence of hearing loss according to age, with older children less likely than younger children to suffer mild or moderate hearing loss.…”

Hearing, Speech, Language, and Communicative Participation in Patients With Apert Syndrome: Analysis of Correlation With Fibroblast Growth Factor Receptor 2 Mutation

“…However, this study did not analyze results by genotype. This is important, because in the general population, the prevalence of OME is 20% at approximately 2 years of age, reducing to 8% by 7 to 8 years of age 65,66,67 . Results of the present study indicated that for patients with a S252W mutation, HL was recorded as long-term for 65% of patients.…”

Absent otoacoustic emissions predict otitis media in young Aboriginal children: A birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia

“…Prevalence The burden of OM and age-specific prevalence in non-Aboriginal children is comparable to that found in studies undertaken elsewhere [1,27,28]. In Aboriginal children, the age-specific prevalence of OM, and specifically the prevalence of TM perforations, in this urban/periurban semi-arid area of WA is lower than in many communities in the NT and WA, though prevalence of disease varies widely between communities [11,29,30].…”

Middle ear disease in Aboriginal children in Perth: analysis of hearing screening data, 1998–2004

“…Consistent with findings reported elsewhere, there was a significant reduction in OME with increasing age. However, the proportion of children in the ≥ 10‐years age group with OME (11.4%) is higher than the 3%–8% reported for non‐Aboriginal children after the age of 7 years 16 . We also found a significant difference in the occurrence of hearing loss according to age, with older children less likely than younger children to suffer mild or moderate hearing loss.…”

Hearing, Speech, Language, and Communicative Participation in Patients With Apert Syndrome: Analysis of Correlation With Fibroblast Growth Factor Receptor 2 Mutation

“…However, this study did not analyze results by genotype. This is important, because in the general population, the prevalence of OME is 20% at approximately 2 years of age, reducing to 8% by 7 to 8 years of age 65,66,67 . Results of the present study indicated that for patients with a S252W mutation, HL was recorded as long-term for 65% of patients.…”